Why is Remedium Life falling/rising?

As of 17-Sep, Remedium Lifecare Ltd's stock price is currently at 1.50, reflecting a decrease of 0.01 or 0.66%. The stock has been underperforming, having fallen consecutively for the last two days with a total decline of 1.32%. In the context of recent performance, the stock has shown a 1.35% increase over the past week, but it has significantly underperformed the sector by 1.44%. The company has a high Debt to EBITDA ratio of -1.00 times, indicating a low ability to service debt, and it has reported negative results for the last four consecutive quarters, contributing to a substantial decline in net sales of 76.36%. These factors, combined with a poor long-term growth outlook, have negatively impacted investor sentiment.
In the broader market context, while the Sensex has increased by 1.56% over the past week, Remedium Lifecare's short-term performance has lagged behind this benchmark. The stock's year-to-date performance shows a drastic decline of 58.03%, contrasting sharply with the Sensex's gain of 5.83%. This underperformance is further highlighted by the stock's return of -76.99% over the past year, compared to the market's slight decline of -0.46%. Overall, the combination of negative financial results, high debt levels, and poor growth prospects has contributed to the stock's downward movement, despite some recent increases in investor participation.